To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.

H.R. 413 · 113th Congress · Jan 23, 2013 · Lineage

A BILL

Section 1 Eliminating the 2-year delay in implementation of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system

Section 632(b) of the American Taxpayer Relief Act of 2012 (Public Law 112–240) is amended by striking all that precedes “With respect to the implementation” and inserting the following::

“(b) Monitoring of implementation of oral-Only ESRD-Related drugs in the ESRD prospective payment system—With respect to the implementation”

Lineage

Jan 23, 2013viewing Introduced in House Mr. Welch (for himself, Mr. Hanna, Mr. Cooper, and Mr. Braley of Iowa) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.

Section 1 Eliminating the 2-year delay in implementation of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system

Cite this provision

Incoming references